Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Contact Us Sitemap Sign In Register
Link to Homepage About AHAF
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when submission deadlines are announced please click on the link below.

Sign up for new RFP announcements and submission deadline notifications.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research funding through the American Health Assistance Foundation (www.ahaf.org). Please follow instructions on the notification emails for removal requests.
 
AHAF Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

  

Macular Degeneration Research - Current Award

Photo of Dr. Justine Smith

Justine Smith, M.D., Ph.D.

Oregon Health and Science University
Portland, OR

Title: Novel Molecular Regulators of Choroidal Neovascularization in Age-Related Macular Degeneration
Non-Technical Title: Control of New Blood Vessel Growth in Macular Degeneration

Duration: April 1, 2008 - June 29, 2010
Award Type: Standard
Award Amount: $100,000


Summary:

This research group has developed a technique for isolation of endothelial cells of the choroid from human eyes that are supplied by the Lions Eye Bank of Oregon. In this project, they will study three molecules that are produced at high levels in tissues related to AMD. They will test the ability of these molecules to control the formation of new blood vessels.

Details:

Age-related macular degeneration or AMD - the leading cause of blindness in adults aged over 60 years - is characterized by damage to the portion of the retina responsible for reading vision. One key player in the development of AMD is the endothelial cell. Endothelial cells line the blood vessels of the body. In the most severe form of AMD, endothelial cells grow from the tissue adjacent to the retina, which is known as the choroid, into the retina. The new blood vessels formed by these choroidal endothelial cells leak blood cells and proteins into the retina. Recently it has been realized that endothelial cells in different parts of the body differ in terms of the molecules they contain. Work from my laboratory has showed that choroidal endothelial cells have a unique molecular composition. This observation implies that it should be possible to develop drugs against molecules that are uniquely expressed in choroidal endothelial cells for treating severe AMD. In this project, we will study three molecules that are produced at high levels by choroidal endothelial cells. We will test the ability of these molecules to control the formation of blood vessels by choroidal endothelial cells in a culture dish. Endothelial cells that line the blood vessels are key players in the development of AMD. In the most severe form of AMD, endothelial cells grow from the tissue adjacent to the retina (choroid), into the retina. The new blood vessels formed by these choroidal endothelial cells leak blood cells and proteins into the retina. Choroidal endothelial cells have a unique molecular composition, and it may be possible to develop drugs against molecules in these cells to treat severe AMD. This study will focus on three molecules produced at high levels by choroidal endothelial cells. It may determine whether manipulating the levels of these molecules could be used therapeutically in patients with AMD.